Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Prenetics Global Limited

Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.

msh id	COM:PRENETICS
symbol	PRE
name	Prenetics Global Limited
homepage url	https://www.prenetics.com
country	HK
sector	Healthcare
industry	Medical - Diagnostics & Research
market	STOCKS
employee count	320
crunchbase url	-
linkedin url	-
founders	-

market cap	73.3M
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	-0.72
growth cost of revenue	-0.91
growth depreciation and amortization	1.01
growth ebitda	-2.18
growth ebitda ratio	-15.99
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-1
growth gross profit	-0.93
growth gross profit ratio	-0.15

COM:PRENETICS

Prenetics

Last Close

4.65

21/11 21:00

Market Cap

54.00M

Beta: -

Volume Today

14.74K

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	74.26M
cost of revenue	74.26M
depreciation and amortization	1.44M
ebitda	-51.08M
ebitda ratio	-2.35
eps	-5.58
eps diluted	-5.58
operating expenses	61.34M
operating income	-52.51M
operating income ratio	-2.42

accounts receivables	-
capital expenditure	-
cash at beginning of period	146.66M
cash at end of period	146.66M
inventory	3.13M
working capital ttm	64.85M

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-